-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 21, Puli Pharmaceuticals announced that the concentrated solution of levetiracetam for injection has been approved by the Food and Drug Administration of Thailand
Levetiracetam injection concentrated solution is an anti-epileptic drug, mainly used for the adjuvant treatment of patients with the following symptoms: add-on treatment of partial seizures in children 4 years and older and adults with epilepsy; adolescents 12 years and older Add-on treatment for myoclonic seizures in adult patients with epilepsy; add-on treatment for primary tonic-clonic seizures in children and adults 12 years of age and older with idiopathic generalized seizures